Adrenal steroids in adrenomyeloneuropathy: Dehydroepiandrosterone sulfate, androstenedione and 17α-hydroxyprogesterone

Journal of Neurology

Volumn 252, Issue 12, 2005, Pages 1525-1529

  Wichers Rother, Maria ^a   Grigull, Andreas ^a   Sokolowski, Piotr ^b   Stoffel Wagner, Birgit ^a   Köhler, Wolfgang ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Department of Neurology   (Germany)

Author keywords

17 hydroxyprogesterone; AMN; Androstenedione; DHEAS; Hypocortisolism

Indexed keywords

ANDROSTENEDIONE; CORTICOSTEROID; HYDROXYPROGESTERONE; PRASTERONE SULFATE;

ADDISON DISEASE; ADOLESCENT; ADRENAL FUNCTION; ADRENOLEUKODYSTROPHY; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; SPINAL CORD; STATISTICAL SIGNIFICANCE;

17-ALPHA-HYDROXYPROGESTERONE; ADRENOLEUKODYSTROPHY; ADULT; AGED; ANDROSTENEDIONE; ANTI-INFLAMMATORY AGENTS; DEHYDROEPIANDROSTERONE SULFATE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 29144502080     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-005-0908-7     Document Type: Article

References (36)

1. Allen JP, Kepic T, Garwacki D, Yunus M (1982) Adrenal defect in adrenomyelodystrophy. South Med J 75:877-879
2. Arlt W, Callies F, Van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
3. Assies J, Gooren LJG, Van Geel B, Barth PG (1997) Signs of testicular insufficiency in adrenomyeloneuropathy and neurological asymptomatic X-linked adrenoleukodystrophy: a retrospective study. Int J Androl 20:315-321
4. Assies J, Van Geel B, Barth P (1998) Low dehydroepiandrosterone sulphate (DHEAS) levels in X-linked adrenoleukodystrophy. Clin Endocrinol (Oxf) 49:691-693
5. Assies J, Haverkort EB, Lieverse R, Vreken P (2003) Effect of dehydroepandrosterone supplementation on fatty acid and hormone levels in patients with X-linked adrenoleukodystrophy. Clin Endocrinol (Oxf) 59:459-466
6. Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84:3896-3902
7. Baulieu EE (1991) Neurosteroids: a new function in the brain. Biol Cell 71:3-10
8. Baulieu EE, Robel P (1996) Dehydroepiandrosterone and dehydroepiandrosterone sulphate as neuroactive neurosteroids. J Endocrinol 150:S221-S239
9. Blevins LS, Shankroff JJ, Moser HW, Landenson PW (1994) Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy. J Clin Endocrinol Metab 78:261-265
10. Brennemann W, Köhler W, Zierz S, Klingmüller D (1996) Occurrence of adrenocortical insufficiency in adrenomyeloneuropathy. Neurology 47:605
11. Brennemann W, Köhler W, Zierz S, Klingmüller D (1997) Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol 137:34-39
12. Depreter M, Vandesompele J, Espeel M, Speleman F, Roels F (2002) Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications. J Endocrinol 175:779-792
13. Di Biase A, Merendino N, Avellino C, Cappa M, Savati S (2001) Th 1 cytokine production by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy. J Neurol Sci 182:161-165
14. Dubois-Dalcq M, Feigenbaum V, Aubourg P (1999) The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 22:4-12
15. Elmlinger MW, Dengler T, Weinstock C, Kuehnel W (2003) Endocrine alterations in the aging male. Clin Chem Lab Med 41:934-941
16. Gaertner J, Dehmel T, Klusmann A, Roerig P (2002) Functional characterization of the adrenoleukodystrophy protein (ALDP) and disease pathogenesis. Endocr Res 28:741-748
17. Hansen SL, Fjalland B, Jackson MB (1999) Differential blockade of gamma-aminobutyric acid type A receptor by the neuroactive steroid dehydroepiandrosterone sulphate in posterior and intermediate pituitary. Mol Pharmacol 55:489-496
18. Judd AM, Call GB, Barney M, McIlmoil CJ, Balls AG, Adams A, Oliveira GK (2000) Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci 917:628-637
19. Kipper-Galperin M, Galilly R, Danenberg HD, Brenner T (1999) Dehydroepiandrosterone selectively inhibits production of tumor necrosis factor α and interleukin-6 in astrocytes. Int J Dev Neurosci 17:765-775
20. König A, Happle R, Tichitcherina E, Schaefer JR, Sokolowski P, Köhler W, Hoffmann R (2000) An X-linked gene involved in androgenetic alopecia: a lesson to be learned from adrenoleukodystrophy. Dermatology 200:213-218
21. Korenke GC, Roth C, Krasemann E, Hüfner M, Hunnemann DH, Hanefeld F (1997) Variability of endocrinological dysfunction in 55 patients with x-linked adrenoleucodystrophy: clinical, laboratory and genetic findings. Eur J Endocrinol 137:40-47
22. Majewska MD, Demirgoren S, Spivak CE, London ED (1990) The neurosteroid dehydroepiandrosterone sulphate is an allosteric antagonist of the GABA A receptor. Brain Res 526:143-146
23. Moser HW, Moser AE, Singh I, O'Neill BP (1984) Adrenoleukodystrophy: Survey of 303 cases: biochemistry, diagnosis and therapy. Ann Neurol 16:628-641
24. th ed. New York, McGraw-Hill, pp 2325-2349
25. Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120:1485-1508
26. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporter. Nature 361:726-730
27. th ed. Philadelphia, Saunders, pp 517-664
28. Parker CR, Mixon RL, Brissie RM, Grizzle WE (1997) Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab 82:3898-3901
29. Parker CR (1999) Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64:640-647
30. Powers JM, Schaumburg HH, Johnson AB, Raine CS (1980) A correlative study of the adrenal cortex in adrenoleukodystrophy - evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol 3:353-376
31. Powers JM, Schaumburg HH (1981) The testis in adreno-leukodystrophy. Am J Pathol 102:90-98
32. Powers JM (1985) Review article: Adreno-leukodystrophy (Adrenotesticulo-leukomyelo-neuropathic-complex). Clin Neuropathol 4:181-199
33. Van Geel BM, Assies J, Wanders RJA, Barth GP (1997) X-linked adrenoleukodystrophy: clinical presentation, diagnosis and therapy. J Neurol Neurosurg Psychiatry 63:4-14
34. Whitcomb RW, Linehan WM, Knazek RA (1988) Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest 81:185-188
35. Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C (1997) Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 82:2363-2367
36. Yamamoto T, Yamanaka T, Matsunaga T (1998) Effects of the neurosteroid dehydroepiandrosterone sulphate on medial vestibular nucleus neurons. Acta Otolaryngol 118:185-191